close

Barrier-first aesthetics

Why ChitoCare Beauty integrates seamlessly into modern clinical practice





As advanced aesthetic treatments continue to evolve, so too does the responsibility placed on clinics to protect long-term skin health. Energy-based devices, resurfacing procedures and active-led protocols all depend on one critical factor: how well the skin barrier tolerates and recovers from intervention. Increasingly, forward-thinking practitioners are recognising that true results are not driven by intensity alone, but by resilience.

Positioned within this shift is ChitoCare Beauty, a brand rooted in Icelandic biotechnology and designed specifi cally to support the skin before, during and after professional  treatment.

As Giorgiana Cardos, Co-Founder & CEO of The ASKA Group, explains: “As the gateway to the Nordics, The ASKA Group is delighted to introduce UK clinics to some of the most innovative skincare and wellness brands from the region. Icelandic skincare in particular stands out for its purity, scientific integrity and bioactive potency, qualities that align perfectly with today’s clinical expectations around results, transparency and skin health.

Among our portfolio, ChitoCare Beauty is a true example of Icelandic innovation. Its formulations are powered by chitosan, a naturally occurring marine biopolymer with exceptional benefi ts for skin comfort, barrier repair, hydration and visible infl ammation reduction. This makes ChitoCare Beauty uniquely well-suited for clinics seeking clean yet clinically supported solutions that elevate both treatment outcomes and at-home recovery.

With patients increasingly looking for products rooted in provenance, purity and evidence, Icelandic skincare offers something truly distinct. ChitoCare Beauty embodies these values, combining nature, biotechnology and performance, and provides clinics with a versatile, trustworthy addition that enhances protocols, supports recovery and complements a wide range of existing services.”

At the core of the range is Icelandic chitosan, a marine-derived biopolymer long studied in biomedical contexts for its film-forming and protective properties. In cosmetic formulations, chitosan forms a thin, breathable, biocompatible film that helps reduce transepidermal water loss, improve comfort and reinforce barrier integrity without the heaviness of traditional occlusives. This makes it particularly relevant in clinics where the barrier is routinely challenged by devices and active treatments.


One of the strengths of ChitoCare is its compatibility with a wide spectrum of non-invasive technologies.

Sigga Vigfúsdóttir, Founder & Managing Director of ChitoCare Beauty, expands:
“ChitoCare Beauty was created to support skin at every stage of its regeneration journey, which is why the range integrates so effortlessly into clinical treatment plans. Our formulations centre around Icelandic chitosan, a natural biopolymer with exceptional skin-repairing, hydrating and soothing properties. This makes the line particularly valuable in environments where the skin barrier is frequently challenged by procedures, devices and advanced aesthetic treatments.

One of the strengths of ChitoCare Beauty is its compatibility with a wide spectrum of non-invasive technologies. The products work beautifully alongside electroporation, sonophoresis, ultrasonic modalities, warm iontophoresis, LED therapy and cosmetic-grade RF, where they help enhance product penetration, calm visible redness and improve post-treatment comfort. For clinics using microneedling, peels or nonablative laser, the range provides gentle yet effective support once the skin surface is intact, helping to reinforce the barrier, restore hydration and accelerate visible recovery.

Clinics also find that ChitoCare Beauty fi ts naturally into multi-step protocols.


It can be used as a preparatory phase to condition the skin ahead of device-led treatments, as a restorative ‘recovery layer’ post-procedure, and as a maintenance solution to prolong results between appointments. At-home product recommendations further strengthen outcomes by supporting the skin daily with lightweight, non-occlusive formulas that continue to calm, protect and rebuild.

Beyond its clinical synergy, the range also performs exceptionally well as a standalone facial experience. Because the textures are lightweight, mineral-rich and instantly comforting, patients see improvements in radiance, suppleness and skin comfort right away, making it an appealing choice for those seeking results without downtime. It allows clinics to offer a replenishing, sensorial treatment that remains grounded in science and barrier health.”

Clinically, this integration is supported by compatibility across a broad device portfolio, including electroporation, sonophoresis, ultrasound cavitation, LED therapy, warm iontophoresis, cold galvanic therapy, cosmeticgrade radiofrequency (40–50°C surface temperatures), ultrasonic skin scrubber and microdermabrasion on intact skin. Structured postprocedure regimens, once the epidermis is fully intact, support recovery following microneedling, superfi cial-to-medium peels and nonablative laser, centring on hydration, comfort and barrier reinforcement.

For clinics, the opportunity is twofold: enhanced treatment experience in-room, and structured retail pathways that extend outcomes beyond the appointment. In a market increasingly focused on skin longevity and barrier preservation, ChitoCare Beauty offers not just compatibility, but strategic alignment, supporting advanced aesthetics while protecting the very tissue on which visible results depend.
Recommended
© Wigmore Medical is a registered pharmacy: no. 9012271